1. Introduction {#s0005}
===============

Due to the difficulty of eradicating infections caused by *Staphylococcus aureus* by its high capacity to develop antibiotic resistance and virulence factors such as biofilm, the optional treatment with new antimicrobial agents is necessary. The phytomedicine is a very interesting therapeutic alternative because the plant extracts are multi-components that could act on multiple targets by different action mechanisms. Some countries have begun to look at their locally available traditional medicines as a means to drug new discovery.

*Zuccagnia punctata* Cav. (Fabaceae) is used for many years in traditional medicine in Argentina ([@b0010]) as antimicrobial and anti-inflammatory ([@b0150]). Antioxidant properties ([@b0095]), antifungal activity ([@b0135], [@b0130], [@b0005], [@b0105], [@b0100]), antibacterial activity against antibiotic resistant Gram-negative bacteria ([@b0175]) and *Streptococcus pneumoniae* ([@b0180]), activity on P-glycoprotein, a membrane ABC transporter ([@b0020]), antigenotoxic properties ([@b0170]), and antiulcer activity ([@b0035]) were reported for *Z. punctata* ethanolic extracts. Some bioactive phenolic constituents and major components of *Z. punctata* ethanolic extracts were also reported ([@b0135], [@b0175], [@b0005], [@b0105]).

The aim of the present work was to evaluate the effect of *Z. punctata* extracts and their major chemical constituents on *S. aureus* growth and virulence factor production as well as pro-inflammatory enzyme inhibition in order to validate its popular use. The toxicity (mutagenic and acute toxicity) was also evaluated.

2. Experimental {#s0010}
===============

2.1. Extraction, isolation and compounds identification {#s0015}
-------------------------------------------------------

The aerial parts of *Z. punctata* Cav. (voucher specimen N° 605,935/LIL, Herbarium of "Fundación Miguel Lillo") was collected from Monte region of Argentina. The plant samples, were dried at 40 °C grounded, macerated and extracted with dichloromethane (DCM) (800 mL) to obtain a non-polar extract of *Z. punctata* (ZpE). Then, ZpE was dried by rotary evaporator to obtain the yield in dry weight. The extract was resuspended in methanol and subjected to bio-guided fractionation by Silica gel, Sephadex LH-20 and C18-column. The fractions with antibiotic activity were analyzed with HPLC--ESI-MS/MS for compounds identification ([@b0105]). The major compounds identified in these fractions were: 2′,4′-dihydroxy-3′-methoxychalcone (DHMC), 2′,4′-dihydroxychalcone (DHC), 7-hydroxyflavanone (7-HF) and 3,7-dihydroxyflavone (DHF). These compounds were also quantified. A calibration curve was prepared using commercial standards to determine the relationship between the peak area and concentration. The compounds concentration was expressed as μg/mg of ZpE. Three replicates were used for all samples.

The antibacterial activity of each fraction was tested by bioautographic and broth microdilution assays ([@b0165], [@b0025]).

2.2. Effect of Zp extract and major components on planktonic cells growth and biofilm formation {#s0020}
-----------------------------------------------------------------------------------------------

### 2.2.1. Microorganisms {#s0025}

Seven clinical isolates of *S. aureus* (F2, F5, F7, F8, F22, F23 and F31) with different antibiotic resistance profile obtained from patients of the Hospital Nicolás Avellaneda, San Miguel de Tucumán, Tucumán, Argentina were used. A strain of American Type Culture Collection (ATCC 10231) was also used. The inocula were prepared by adjusting the suspension turbidity to match the 0.5 McFarland standards (10^8^ CFU/mL).

### 2.2.2. Activity against planktonic cells {#s0030}

The activity of ZpE and pure compounds on *S. aureus* was analyzed by a broth microdilution method according to the CLSI reference M100S17 ([@b0025]). Assayed natural products were dissolved in 1% dimethyl sulfoxide (DMSO) to obtain final concentrations between 125 to 500 μg of dry weight per mL (μg/mL) for the ZpE and between 25 to 400 μg/mL for each fraction and pure compound. The inoculum (100 μL of Mueller Hinton broth containing 1 × 10^7^ CFU/mL) was added to each well. Plates were incubated at 37 °C for 24 h. Aliquots of 10 μL of each well without visible growth were inoculated onto the surface of Mueller Hinton agar. The MIC and MBC values were determined.

### 2.2.3. Bioautographic assay {#s0035}

The *Z. punctata* aerial parts extracts were spotted on silica gel TLC and developed using CHCl~3~:MeOH (9:1) as the mobile phase. Then, the plates were covered with soft medium (BHI with 0.6% agar) containing 10^5^ CFU of a methicillin resistant *S. aureus* (F7), incubated at 37 °C for 16--20 h and revealed with MTT solution (2.5 mg/mL) in PBS according to [@b0165].

### 2.2.4. Effect of natural product on biofilm formation and metabolic activity {#s0040}

*Z. punctata* extract or isolated compounds (20 μL of 1/2 MIC) were added to *S. aureus* (ATCC 25923 and F7 strains) suspension (180 μL of 1 × 10^8^ cells/mL). The plates were incubated at 37 °C during 24 h and then, the medium was aspirated, and non-adherent cells were removed by washing with sterile PBS. Ciprofloxacin (50 μg/mL) was used as positive control.

Finally, 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-\[(phenylamino)-carbonyl\]-2H-tetrazolium hydroxide (XTT) or crystal violet was added to determine the effect of natural product on metabolic activity and biofilm formation, respectively ([@b0050]).

### 2.2.5. Electron microscopy {#s0045}

*S. aureus* suspension (100 μl of 1 × 10^8^ cells of F7 strain/mL) was added to 100 μL of PBS or DHC at the MIC concentration. All tubes were incubated 24 h with stirring (500 rpm). Then, were submitted to centrifugation for 5 min at 5000*g* and the pellets were re-suspended in PBS.

#### 2.2.5.1. Scanning electron microscopy (SEM) {#s0050}

Untreated cells and cells exposed to DHC were processed for electron microscopy according to [@b0145] using 4% (v/v) formaldehyde and 2% (v/v) glutaraldehyde in PBS, washed thoroughly in the same buffer, post-fixed in 1% (w/v) osmium tetroxide and dehydrated in alcohol (70% and 100%). Then, the cells were treated with hexamethyldisilazane for 5 min. The dehydrated samples were critical point-dried and then coated with gold/palladium (40%/60%), before viewing using a Zeiss-supra 55VP scanning electron microscope operated at high vacuum at 15 kV.

#### 2.2.5.2. Transmission electron microscopy (TEM) {#s0055}

The treated and non treated cells were placed in contact with 0.3% terpinen-4-ol and then were fixed over night with 2.5% of glutaraldehyde, and dehydrated in alcohol, propylene oxide and araldite. The dehydrated samples were embedded in resin, sectioned and stained according to [@b0015] before examination using a Zeiss-EM 109 transmission electron microscope operated at an accelerating voltage of 80 kV.

2.3. Effect of ZpE and selected major constituents upon pro-inflammatory enzymes {#s0060}
--------------------------------------------------------------------------------

### 2.3.1. Cyclooxygenase (COX) inhibition assay {#s0065}

The inhibitory activity of the samples was determined using the COX inhibitor assay screening kit (Cayman Chemical Co., Ann Arbor, MI, USA). Prostaglandins (PGs), which are produced in the COX-2 reaction, were quantified via enzyme immunoassay with a specific antibody that binds to major PG compounds ([@b0030]). The natural products at various concentrations in DMSO were tested. DMSO was used in the control of 100% COX-2 activity. Nimesulide and indomethacin were used as positive controls.

### 2.3.2. Lipoxygenase (LOX) inhibition assay {#s0070}

The assay was carried out by monitoring the LOX-mediated transformation of linoleic acid into lipidic hydroperoxide at 234 nm. The reaction mixtures contained the following reagents: soybean LOX-1 (0.9 mM), in borate buffer 0.2 M, pH 9.0, tested natural products at various concentrations in DMSO (25--200 μg/mL), and linoleic acid (50 μM). The increase in absorbance was monitored for 4 min ([@b0030]). The negative control was DMSO, and the positive controls were naproxen and caffeic acid.

### 2.3.3. Phospholipase (sPLA~2~) inhibition assay {#s0075}

The substrate for sPLA~2~ were micelles of 1,2-di (heptanoylthio) glycerophosphocholine (1.25 mM) with Triton X-100 (0.3 mM) ([@b0030]). The substrate was dissolved in 10 mM Tris--HCl (pH 8) containing 10 mM CaCl~2~ and 100 mM KCl. Ten microlitre of sPLA~2~ (1 μg/mL) was added to 50 μL of the buffer, 10 μL of 5,5′- dithio-*bis*-2-nitrobenzoic acid (DTNB) 10 mM and 5 μL of natural products in DMSO (10 μg/mL). The reaction was initiated with 150 μL of substrate and measuring absorbance at 415 nm for 20 min at 25 °C. The negative control was DMSO, and the positive control was naproxen.

2.4. Toxicity assay {#s0080}
-------------------

### 2.4.1. General toxicity assay {#s0085}

The acute toxicity levels of ZpE and isolated compounds were studied using *Artemia salina* as test organism ([@b0125]). Different concentrations of DHC (12.5--50 μg/mL), DHMC, HF, DHF (50--200 μg/mL) or ZpE (125--500 μg/mL) were used.

### 2.4.2. Mutagenicity test {#s0090}

The assays were performed according to [@b0090], with the *Salmonella typhimurium* TA98 and TA100 strain using different concentrations for ZpE and isolated compounds (until 250 μg per plate). Negative and positive controls were used simultaneously in each experiment. The positive control was 4-nitro-o-fenilendiamine (10 μl per plate, 1 mg/mL solution) for TA98 and TA100, and the negative control was DMSO (100 μl per plate). His + revertants were counted after 48 h of incubation at 37 °C. The test substance was considered mutagenic if it reproducibly induced a twofold increase in the number of mutants with at least one concentration, compared to the corresponding negative control (mutagenicity relationship).

2.5. Statistical analysis {#s0095}
-------------------------

The data determined were expressed as the mean of three replicate determinations and the values of relative standard deviation (RSD) \<10% were considered to meet the demands for bioanalytical assay. The IC~50~ values were estimated by linear/non-linear regression.

3. Results and discussion {#s0100}
=========================

3.1. Antimicrobial activity {#s0105}
---------------------------

In this paper we analyzed the antibiotic potency of *Z. punctata* non-polar extract and major compounds previously isolated ([@b0105]), against seven *S. aureus* strains isolated from infections of patients from an hospital of Tucumán, Argentina, and a collection strain.

The HPLC analysis showed that the contents of DHMC, DHC, DHF and HF were 92.61, 109.4, 22.53 and 28.93 μg/mg of ZpE, respectively; corresponding to 9.3, 10.9, 2.3, 2.9% of the extract weight.

It was shown that all assayed natural products affect the normal growth of all clinical isolates of *S. aureus* and the ATCC strains. The MIC values for ZpE were between 125 and 500 μg/mL and MBC values indicated that the extract was active on 60% of strains. For the isolated compounds, the MIC values were between 25 and 400 μg/mL and the MBC values were between 50 and \>400 μg/mL against all strains assayed ([Table 1](#t0005){ref-type="table"}).Table 1Antibacterial activity of *Z. punctata* dichloromethanic extract (ZpE) and the major isolated compounds against antibiotic sensible and resistant *Staphylococcus aureus.*N° strainsZpEDHCDHMCHFDHFFenotype of clinical isolateMIC/MBC (μg/mL)2250/R^∗^25/50200/40050/R^∗^25/400Met^r^ Oxa^r^ Gen^r^ Van^s^5125/50025/100200/200200/R^∗^200/R^∗^Met^r^ Oxa^r^7500/R^∗^25/100200/200200/200200/R^∗^Met^r^ Oxa^r^ Gen^r^8125/50025/100200/20025/R^∗^25/400Met^r^ Oxa^r^22250/R^∗^25/400200/R^∗^25/R^∗^25/R^∗^Met^r^ Oxa^r^ Gen^r^ Van^s^23125/25025/200100/200200/R^∗^200/R^∗^Met^r^ Oxa^r^31125/250100/200200/200200/R^∗^200/R^∗^Met^r^ Oxa^r^ Van^s^ATCC 29213125/25050/50200/200200/R^∗^400/R^∗^Control strain[^1][^2]

The ZpE showed similar or greater potency as compared to aqueous and hydroalcoholic extracts of the same and other xerophyte plant species collected in arid environments of Northwest Argentina against Gram positive and Gram negative bacteria ([@b0175], [@b0165], [@b0180]). Isolated compounds showed greater potency than the extract, the order of reactivity for these latter was DHC \> DHF = HF \> DHMC. Previously other authors reported that OH groups of chalcones induce and enhance the antimicrobial activity, while the methoxy groups in the structure of chalcones decrease or eliminate the antimicrobial activity ([@b0070]). Moreover, the unsaturated chain of DHC between rings A and B, was not a determinant of *S. aureus* antimicrobial activity since the flavone and flavanone exhibit similar antimicrobial activity. The compound DHC showed a similar or higher inhibitory effect against *S. aureus* growth than others hydroxylated chalcones on the ring B and flavones previously reports (2′,4,6′-trihydroxy-4′- metoxychalcone, 3,5-dihydroxy-6,7,8-trimetoxyflavona, apigenin and luteolin) ([@b0045], [@b0120], [@b0160]).

*S. aureus* treated with DHC was observed by electron microscopy (SEM and TEM) to confirm the antimicrobial efficacy of the chalcone along with the morphological changes in the cell appearance. [Fig. 1](#f0005){ref-type="fig"} showed that the treated bacteria with MIC values of DHC produce visible cellular aggregation, blebs on the cellular surface and cytoplasmic coagulation. The formation of blebs is an indicator of membrane damage because the total leakage of cytoplasmic material was not observed. The compound DHC produced cytoplasmic coagulation of *S. aureus* cell, evidenced by dark areas in the cells, as exemplified by [Fig. 1](#f0005){ref-type="fig"}IV ([@b0055]). [@b0115] reported that a flavonol (epicatechin gallate) promoted staphylococcal cell aggregation and increases cell-wall thickness.Figure 1Electron microscopy of *Staphylococcus aureus* cells (I, III) untreated (control) and (II, IV) treatment with 50 mg/mL 2′,4′-dihydroxychalcone. I and II SEM. III and IV TEM. Key to arrows: A, aggregation; B, blebbing; CC, cytoplasmic coagulation; MD, membrane damage.

3.2. Biofilm inhibition {#s0110}
-----------------------

Pathogenicity of microorganisms depends on the virulence factors developed to produce adhesion and invasion of host. Not all antibiotics are able to inhibit these virulence factors, hence the importance of finding alternative treatments. Therefore, biofilm formed by methicillin-resistant *S. aureus* have become resistant to most available antimicrobial agents, including the β-lactams ([@b0085]). For these reasons, it is interesting to study the effect of ZpE and isolated compounds on biofilm formation by *S. aureus.* The effect of the samples was evaluated on biofilm formation by two strains of *S. aureus* a clinical isolate (F7 strain) and a collection strain (ATCC 25923), which showed increased adherence to microplates. [Fig. 2](#f0010){ref-type="fig"} shows that the ZpE and the isolated compounds inhibit biofilm formation and reduce the metabolism of cells embedded in it. The DHC was the most active pure compound in inhibiting *S. aureus* biofilm formation. [@b0060] reported inhibition of biofilm formation by flavonoids. While [@b0040] demonstrated biofilm activity for other natural and synthesized chalcones against Gram positive bacteria.Figure 2The percent of biofilm formation inhibition (A) and metabolism decrease (B) by *Zuccagnia punctata* (ZpE) and pure metabolites. Methicillin resistant *Staphylococcus aureus* (MRSA) F7 strain and ATCC 25923 strain. DHC: 2′,4′-dihydroxychalcone; DHMC: 2′,4′-dihydroxy-3′-methoxychalcone. HF: 3-hydroxyflavanone; DHF: 3,7-dihydroxyflavone; ZpE: *Z. punctata* extract; CIP: Ciprofloxacin. Data are presented as mean values ±SD (*p* *\<* 0.05).

Furthermore, the present study is the first report of medicinal species extracts from arid environments of Argentina that inhibit biofilm formation of *S. aureus*. Vegetal extracts of *Quercus cerris* L. (Fagaceae) showed similar *S. aureus* biofilm inhibition at the concentrations of 200 μg/mL ([@b0075]).

3.3. Anti-inflammatory properties of ZpE and selected major constituents {#s0115}
------------------------------------------------------------------------

In the inflammatory process, the membrane phospholipids are hydrolyzed to produce arachidonic acid by phospholipase enzymes (PLA~s~) and then, this acid is metabolized through the enzymes cyclooxygenases (COXs), and lipoxygenases (LOXs) by different enzymatic pathways to produce prostaglandins, thromboxanes and leucotrienes ([@b0030]).

In this work we investigated the inhibitory effect of ZpE and isolated metabolites on pro-inflammatory enzymes (sPLA**~2~**, LOX and COX-2).

For the secretory phospholipase A~2~ (sPLA**~2~),** DHC was the most active compound follows by ZpE and DHMC, HF and DHF ([Table 2](#t0010){ref-type="table"}). The low inhibitory activity of flavanones could be due to the absence of the double bond between C2-C3 in the ring B ([@b0080]). The pure compounds were more potent than the commercial anti-inflammatory drug, naproxen.Table 2Inhibitory activity of *Z. punctata* extracts (ZpE) and the major isolated compounds against three pro-inflammatory enzymes.SamplesInhibition (%)IC~50~ (μg/mL)sPLA~2~ (10 μg/mL)LOXCOX-2ZpE40.47 ± 2.0069.30 ± 3.50293.00 ± 20.50DHC60.50 ± 2.9099.50 ± 3.001.72 ± 0.10DHMC38.18 ± 1.8063.40 ± 3.10--HF8.42 ± 0.40155.00 ± 3.1035.00 ± 2.40DHF2.70 ± 0.2057.80 ± 2.9025.50 ± 1.90Naproxen6.00 ± 0.408.14 ± 0.40--Nimesulide----0.39 ± 0.01Indomethacin----0.28 ± 0.01Caffeic acid--57.5 ± 1.1--[^3]

Lipoxygenases are the enzymes responsible for generating hydroxy acids and leucotrienes from arachidonic acid. The compounds DHF and DHMC showed the highest activity with IC~50~ values of 57.8 and 63.4 μg/mL, respectively. The potency of both compounds was similar to the caffeic acid used as control. *Z. punctata* extract also showed important inhibitory activity. The flavanone HF was the less active compound; this is in agreement with [@b0110] who reported that the double bond between C2-C3 in the ring C is important for the LOX inhibitory activity.

Cyclooxygenase-2 is a pivotal enzyme in inflammation, and inhibitors of COX-2 are being continuously developed to obtain safer anti-inflammatory drugs. As present in [Table 2](#t0010){ref-type="table"}, within the examined flavonoids DHC showed the highest COX-2 inhibitory activity with IC~50~ value of 1.72 μg/mL followed by DHF, HF and ZpE. The DHMC was not active against COX-2 at the tested concentrations (10--150 μg/mL). The DHC showed similar activity to the synthetic anti-inflammatory drugs assayed (indomethacin and nimesulide).

To our knowledge the compounds studied in this work were for the first time found as inhibitors of COX-2, LOX and sPLA2 enzymes. However others chalcones, flavones and flavanones were found to be inhibitors of these pro-inflammatory enzymes ([@b0080]).

Chalcone derivatives such as 3,4-dihydroxychalcone, 3,4,2′-trihydroxychalcone, 3,4,4′-trihydroxychalcone and 3,4,2′4′-tetrahydroxychalcone, inhibited LOX and COX activities, being more active on LOX ([@b0080]). In regard to the chalcones evaluated in this work, DHMC was more active on LOX, while DHC was more potent on COX-2. However, weak or no activity was observed on COX by [@b9000] for 4,4′-dihydroxy-2,6-dimethoxydihydrochalcone, 2,4′-dihydroxy-4,6-dimethoxydihydrochalcone, 4′-hydroxy-2,4,6-trimethoxydihydrochalcone,4,6,4′-trihydroxy-2-methoxydihydrochalcone.

A fraction of *Parastrephia lucida* enriched in methoxy flavones strongly inhibited sPLA2 activity ([@b0065]). The flavone DHF at the concentration assayed in our work was not active. On the other hand, [@b0140] suggested that the 4-oxo functional group of the C-ring is essential for the higher COX inhibition activities and that the C2-C3 double-bond enhances the activity; this could be the reason why DHF was more active than the HF.

[@b0155] suggested that 2′,4-dihydroxychalcone; 2′,5′-dihydroxy-indol-3-yl-chalcone; 2′-hydroxy-2-thienylchalcone; 2′-hydroxy-3-tienylchalcone, 2′-hydroxy-3,4-dichlorochalcone and 3,5-di-ter-butyl-2′,4,5′-trihydroxychalcone were potential anti-inflammatory agents.

3.4. Evaluation of acute toxicity {#s0120}
---------------------------------

*A. salina* test is based on the possibility of a toxic compound to kill *A. salina* larvae grown in the laboratory. None of the pure compounds showed toxicity against *A. salina* at the concentrations tested. *Z. punctata* extract showed LC~50~ (concentration that kills 50% of the *A. salina* larvae) value of 250 μg/mL, while the positive control (sodium dichromate) showed a LC~50~ value of 30 μg/mL.

3.5. Mutagenicity assay {#s0125}
-----------------------

In this study, the mutagenicity relationship resulted less than 1.5 for both the ZpE and the isolated compounds; indicating that they were not mutagenic agents. [@b0170] did not find genotoxicity of *Z. punctata* hidroalcoholic extract and DHC using the *in vitro* comet assay test on human hepatoma HepG2 cells.

4. Conclusions {#s0130}
==============

In summary, the ZpE (phytocomplex) and the pure compounds were active against the *S. aureus* clinical isolated and on three pro-inflammatory enzymes (sPLA~2~, LOX and COX), so arachidonic acid metabolism could be inhibited at different levels. The results showed that these natural products could be a good alternative therapy for infective and inflammatory processes but *in vivo* assays are necessary to determine the effectiveness of its use. The mutagenic effect absence is a positive advance for determination of safety use of this medicinal plant species.
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[^1]: ZpE: *Z. punctata* dichloromethanic extract. DHC: 2′,4′-dihydroxychalcone; DHMC: 2′,4′-dihydroxy-3′-methoxychalcone. HF: 3-hydroxyflavanone; DHF: 3,7-dihydroxyflavone. R^∗^: resistent until 500 μg/mL of extract.

[^2]: ^r^Resistant, ^s^Susceptible; methicillin (Met), oxacillin (OXA), gentamycin (Gen), vancomycin (Van).

[^3]: ZpE: *Z. punctata* dichloromethanic extract. DHC: 2′,4′-dihydroxychalcone; DHMC: 2′,4′-dihydroxy-3′-methoxychalcone.; HF: 3-hydroxyflavanone; DHF: 3,7-dihydroxyflavone. Data are presented as mean values ± SD (*n* = 3, *p* *\<* 0.05).
